Literature DB >> 32594787

COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: a tele-medicine experience.

Mohammad Shahidi-Dadras1, Fahimeh Abdollahimajd1, Laya Ohadi1, Mohammadreza Tabary2, Farnaz Araghi1, Nikoo Mozafari1,3, Parviz Toosi1, Sahar Dadkhahfar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32594787     DOI： 10.1080/09546634.2020.1789041

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


× No keyword cloud information.
  8 in total

1.  COVID-19 Pandemic Impact on Severe Alopecia Areata Patients.

Authors:  Mehdi Gheisari; Khatere Zahedi; Zohreh Tehranchinia; Hamideh Moravvej; Fahimeh Abdollahimajd; Sahar Dadkhahfar
Journal:  Skin Appendage Disord       Date:  2021-12-20

2.  The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.

Authors:  Sam Kant; Adam Morris; Srekar Ravi; Lauren Floyd; Eric Gapud; Brendan Antichos; Ajay Dhaygude; Phil Seo; Duvuru Geetha
Journal:  J Nephrol       Date:  2020-10-08       Impact factor: 3.902

3.  Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab.

Authors:  Jo Linda Sinagra; Claudio Vedovelli; Raffaella Binazzi; Adele Salemme; Francesco Moro; Cinzia Mazzanti; Biagio Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

Review 4.  The Outcome of COVID-19 in Patients with a History of Taking Rituximab: A Narrative Review.

Authors:  Pourya Yarahmadi; Mohammad Alirezaei; Seyed Mohammad Forouzannia; Abdorreza Naser Moghadasi
Journal:  Iran J Med Sci       Date:  2021-11

5.  COVID-19 severity and SARS-Cov-2 vaccine safety in pemphigus patients.

Authors:  Züleyha Özgen; Hasan Aksoy; Özlem Akın Çakıcı; Ayşe Esra Koku Aksu; Ozan Erdem; Asude Kara Polat; Mehmet Salih Gürel
Journal:  Dermatol Ther       Date:  2022-03-10       Impact factor: 3.858

Review 6.  Ethical considerations in neurology during the COVID-19 pandemic.

Authors:  Mohammadreza Tabary; Ruhollah Abolhasani; Farnaz Araghi; Armin Aryannejad; Behnam Safarpour Lima
Journal:  Neurol Sci       Date:  2021-01-02       Impact factor: 3.307

7.  Can rituximab be used in the treatment of pemphigus vulgaris during the COVID-19 pandemic?

Authors:  Tugba Kevser Uzuncakmak; Defne Özkoca; Ozge Askin; Zekayi Kutlubay
Journal:  Dermatol Ther       Date:  2020-12-15       Impact factor: 3.858

Review 8.  Teledermatology in the COVID-19 pandemic: A systematic review.

Authors:  Chee Hoou Loh; Steve Yew Chong Tam; Choon Chiat Oh
Journal:  JAAD Int       Date:  2021-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.